{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T13:33:43Z","timestamp":1790948023573,"version":"4.1.0"},"reference-count":41,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:00:00Z","timestamp":1772496000000},"content-version":"unspecified","delay-in-days":61,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"the Key Open Project of the Joint Laboratory of Xinjiang Medical University","award":["SKL-HIDCA-2020-EF1"],"award-info":[{"award-number":["SKL-HIDCA-2020-EF1"]}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2015211C109"],"award-info":[{"award-number":["2015211C109"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2019D01C239"],"award-info":[{"award-number":["2019D01C239"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360858"],"award-info":[{"award-number":["82360858"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2026,2,7]]},"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) is a severe and prevalent complication of SLE. Compound Muniziqi granule (CMG), a traditional remedy, is commonly used to treat immune system-related disorders. However, its efficacy in treating LN remains unassessed. This study aims to evaluate the therapeutic potential of CMG for LN and to explore its molecular mechanisms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>CMG was evaluated for therapeutic effects on LN in Murphy Roths Large (MRL)\/lymphoproliferation (lpr) mice. Renal tissues from mice in the Control, Model and CMG treatment groups were collected for transcriptomic analysis to identify the potential pathways involved in CMG\u2019s action in LN. We then examined the effects of CMG on inflammatory cell infiltration, complement system activation and B-cell accumulation in the renal tissues of MRL\/lpr mice. Additionally, we assessed the impact of CMG on the cluster of differentiation 40 (CD40)\/Nuclear Factor-kappa B p65 (NF-\u03baB p65) signalling pathway in these tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>CMG treatment reduced the spleen index in MRL\/lpr mice, decreased serum levels of antibodies and inflammatory cytokines and improved renal function markers. It also alleviated renal pathological damage and inflammatory infiltration. Transcriptomic analysis indicated that CMG\u2019s therapeutic effects may be linked to \u2018SLE\u2019 and the \u2018NF-\u03baB signalling pathway\u2019. Further investigation revealed that CMG downregulated a wide array of complement-related and inflammation-associated genes. Notably, CMG reduced the gene expression of CD40 and CD40L. In addition, CMG decreased inflammatory cytokine levels. Preliminary immunofluorescence analysis indicated that CMG reduced immune complex deposition and diminished B-cell infiltration in the renal tissues of MRL\/lpr mice. Preliminary western blot analysis indicated that CMG downregulated B Lymphocyte-Induced Maturation Protein 1 (BLIMP1), CD40 and tumour necrosis factor (TNF) receptor-associated factor 6 (TRAF6) expression, as well as the phosphorylation of NF-\u03baB p65.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>CMG effectively mitigates inflammatory infiltration and renal damage in MRL\/lpr mice. Preliminary evidence indicates that this protective effect may be associated with reduced activity of the CD40\/NF-\u03baB p65 signalling pathway, along with decreased B-cell activation and complement system activation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001821","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:25:17Z","timestamp":1772551517000},"page":"e001821","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Mechanistic study of compound Muniziqi granule on lupus nephritis in MRL\/lpr mice: insights from transcriptomics and experimental validation"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7344-6105","authenticated-orcid":false,"given":"Jiyun","family":"Zhang","sequence":"first","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Urumqi Municipality, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9266-0548","authenticated-orcid":false,"given":"Yuming","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Integrative Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-3029-3824","authenticated-orcid":false,"given":"Cuiting","family":"Gong","sequence":"additional","affiliation":[{"name":"Hebei Medical University, Shijiazhuang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2988-081X","authenticated-orcid":false,"given":"Nuerxiati","family":"Tabushi","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Urumqi Municipality, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-3589-8833","authenticated-orcid":false,"given":"Tianxiao","family":"Cui","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Urumqi Municipality, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2209-3744","authenticated-orcid":false,"given":"Dehong","family":"Ma","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-3828-2106","authenticated-orcid":false,"given":"Yerdin","family":"Qimuk","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Urumqi Municipality, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4691-1491","authenticated-orcid":false,"given":"Huan","family":"Pei","sequence":"additional","affiliation":[{"name":"School of Integrative Chinese and Western Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-7301-7127","authenticated-orcid":false,"given":"Xiaojuan","family":"Zhou","sequence":"additional","affiliation":[{"name":"The Second Affiliated Hospital of Xinjiang Medical University, Urumqi Municipality, Xinjiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9303-7341","authenticated-orcid":false,"given":"Weibo","family":"Wen","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7626-8555","authenticated-orcid":false,"given":"Qianqian","family":"Wan","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0820-5436","authenticated-orcid":false,"given":"Huantian","family":"Cui","sequence":"additional","affiliation":[{"name":"First School of Clinical Medicine, Yunnan University of Chinese Medicine, Kunming, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,3,3]]},"reference":[{"key":"2026030307250998000_13.1.e001821.1","doi-asserted-by":"crossref","unstructured":"Ameer MA , Chaudhry H , Mushtaq J , et al . An Overview of Systemic Lupus Erythematosus (SLE) Pathogenesis, Classification, and Management. Cureus 2022;14. doi:10.7759\/cureus.30330","DOI":"10.7759\/cureus.30330"},{"key":"2026030307250998000_13.1.e001821.2","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1002\/acr.24960","article-title":"Evaluation of the EULAR \/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population\u2010Based Registry","volume":"75","author":"Guttmann","year":"2023","journal-title":"Arthrit Care Res"},{"key":"2026030307250998000_13.1.e001821.3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2026030307250998000_13.1.e001821.4","first-page":"257","article-title":"Disease-specific quality of life in patients with lupus nephritis","volume":"27","author":"Jolly","year":"2018","journal-title":"Lupus (Los Angel)"},{"key":"2026030307250998000_13.1.e001821.5","doi-asserted-by":"publisher","DOI":"10.1002\/art.38006"},{"key":"2026030307250998000_13.1.e001821.6","doi-asserted-by":"crossref","first-page":"102871","DOI":"10.1016\/j.jaut.2022.102871","article-title":"Lupus nephritis: new progress in diagnosis and treatment","volume":"132","author":"Yu","year":"2022","journal-title":"J Autoimmun"},{"key":"2026030307250998000_13.1.e001821.7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20246231","article-title":"B Cell Abnormalities in Systemic Lupus Erythematosus and Lupus Nephritis-Role in Pathogenesis and Effect of Immunosuppressive Treatments","volume":"20","author":"Yap","year":"2019","journal-title":"Int J Mol Sci"},{"key":"2026030307250998000_13.1.e001821.8","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4103\/1319-2442.284008","article-title":"Anti-C1q antibodies in lupus nephritis and their correlation with the disease activity","volume":"31","author":"Emad","year":"2020","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"2026030307250998000_13.1.e001821.9","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfy267"},{"key":"2026030307250998000_13.1.e001821.10","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2023.e18711","article-title":"Oral proprietary Chinese medicine for lupus nephritis: A bayesian network meta-analysis","volume":"9","author":"Lin","year":"2023","journal-title":"Heliyon"},{"key":"2026030307250998000_13.1.e001821.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0923-1811(01)00161-X"},{"key":"2026030307250998000_13.1.e001821.12","first-page":"367","article-title":"Effects of langchuangping granule on the expression of B lymphocyte activating factor in the peripheral blood B cells of BXSB lupus nephritis mice","volume":"32","author":"Li","year":"2012","journal-title":"Zhongguo Zhong Xi Yi Jie He Za Zhi"},{"key":"2026030307250998000_13.1.e001821.13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0118462","article-title":"The effects of Jieduquyuzishen prescription-treated rat serum on the BAFF\/BAFF-R signal pathway","volume":"10","author":"Wu","year":"2015","journal-title":"PLoS ONE"},{"key":"2026030307250998000_13.1.e001821.14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jep.2018.05.024","article-title":"Extracts of compound Muniziqi granule suppressed uterus contraction and ameliorated oxytocin-induced primary dysmenorrhea","volume":"223","author":"Wei","year":"2018","journal-title":"J Ethnopharmacol"},{"key":"2026030307250998000_13.1.e001821.15","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1186\/s12906-017-2017-4","article-title":"The inhibitory effects of compound Muniziqi granule against B16 cells and harmine induced autophagy and apoptosis by inhibiting Akt\/mTOR pathway","volume":"17","author":"Zou","year":"2017","journal-title":"BMC Complement Altern Med"},{"key":"2026030307250998000_13.1.e001821.16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12906-016-0999-y","article-title":"In in vivo evaluation of the anti-inflammatory and analgesic activities of compound Muniziqi granule in experimental animal models","volume":"16","author":"Cheng","year":"2015","journal-title":"BMC Complement Altern Med"},{"key":"2026030307250998000_13.1.e001821.17","first-page":"1626","article-title":"Expert Consensus on the Clinical Application of Compound Muniziqi Granules (2024)","volume":"65","author":"Du","year":"2024","journal-title":"J Tradit Chin Med"},{"key":"2026030307250998000_13.1.e001821.18","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-024-03085-9"},{"key":"2026030307250998000_13.1.e001821.19","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1021\/acs.jproteome.3c00558","article-title":"Proteomics-Based Identification of Potential Therapeutic Targets of Artesunate in a Lupus Nephritis MRL\/lpr Mouse Model","volume":"23","author":"Wen","year":"2024","journal-title":"J Proteome Res"},{"key":"2026030307250998000_13.1.e001821.20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.23876\/j.krcp.22.083","article-title":"Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance","volume":"42","author":"Choi","year":"2023","journal-title":"Kidney Res Clin Pract"},{"key":"2026030307250998000_13.1.e001821.21","doi-asserted-by":"crossref","first-page":"F1258","DOI":"10.1152\/ajprenal.00472.2019","article-title":"Expression of XBP1s in B lymphocytes is critical for pristane-induced lupus nephritis in mice","volume":"318","author":"Xiang","year":"2020","journal-title":"Am J Physiol Renal Physiol"},{"key":"2026030307250998000_13.1.e001821.22","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.08.015"},{"key":"2026030307250998000_13.1.e001821.23","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-00993-3"},{"key":"2026030307250998000_13.1.e001821.24","doi-asserted-by":"crossref","DOI":"10.1186\/s13075-019-2038-0","article-title":"ALW peptide ameliorates lupus nephritis in MRL\/lpr mice","volume":"21","author":"Wang","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"2026030307250998000_13.1.e001821.25","doi-asserted-by":"crossref","first-page":"23475","DOI":"10.1038\/s41598-024-72564-z","article-title":"Cytokine profiles and their correlation with clinical and blood parameters in rheumatoid arthritis and systemic lupus erythematosus","volume":"14","author":"Duarte-Delgado","year":"2024","journal-title":"Sci Rep"},{"key":"2026030307250998000_13.1.e001821.26","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.734008","article-title":"Macrophage Polarization and Plasticity in Systemic Lupus Erythematosus","volume":"12","author":"Ahamada","year":"2021","journal-title":"Front Immunol"},{"key":"2026030307250998000_13.1.e001821.27","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/08916934.2018.1494161","article-title":"Immunoregulatory effects of indole-3-carbinol on monocyte-derived macrophages in systemic lupus erythematosus: A crucial role for aryl hydrocarbon receptor","volume":"51","author":"Mohammadi","year":"2018","journal-title":"Autoimmunity"},{"key":"2026030307250998000_13.1.e001821.28","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/BOR.0000000000000317","article-title":"Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus","volume":"28","author":"Couture","year":"2016","journal-title":"Curr Opin Rheumatol"},{"key":"2026030307250998000_13.1.e001821.29","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2015.33"},{"key":"2026030307250998000_13.1.e001821.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2023.08.033"},{"key":"2026030307250998000_13.1.e001821.31","doi-asserted-by":"crossref","unstructured":"Yung S , Yap DY , Chan TM . A review of advances in the understanding of lupus nephritis pathogenesis as a basis for emerging therapies. F1000Res 2020;9. doi:10.12688\/f1000research.22438.1","DOI":"10.12688\/f1000research.22438.1"},{"key":"2026030307250998000_13.1.e001821.32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.179.5.3351"},{"key":"2026030307250998000_13.1.e001821.33","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfs285"},{"key":"2026030307250998000_13.1.e001821.34","doi-asserted-by":"crossref","first-page":"7321","DOI":"10.1038\/s41467-022-34969-0","article-title":"A p38\u03b1-BLIMP1 signalling pathway is essential for plasma cell differentiation","volume":"13","author":"Wu","year":"2022","journal-title":"Nat Commun"},{"key":"2026030307250998000_13.1.e001821.35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023239","article-title":"CD40 is essential in the upregulation of TRAF proteins and NF-kappaB-dependent proinflammatory gene expression after arterial injury","volume":"6","author":"Song","year":"2011","journal-title":"PLoS One"},{"key":"2026030307250998000_13.1.e001821.36","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2018.12.005"},{"key":"2026030307250998000_13.1.e001821.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2020.102668"},{"key":"2026030307250998000_13.1.e001821.38","doi-asserted-by":"publisher","DOI":"10.1002\/art.10273"},{"key":"2026030307250998000_13.1.e001821.39","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2024-001220","article-title":"Curcumin attenuates lupus nephritis by inhibiting neutrophil migration via PI3K\/AKT\/NF-\u03baB signalling pathway","volume":"11","author":"Yang","year":"2024","journal-title":"Lupus Sci Med"},{"key":"2026030307250998000_13.1.e001821.40","doi-asserted-by":"crossref","DOI":"10.1093\/gpbjnl\/qzaf072","article-title":"The GSA Family in 2025: A Broadened Sharing Platform for Multi-omics and Multimodal Data","volume":"23","author":"Zhang","year":"2025","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"2026030307250998000_13.1.e001821.41","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkae978"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T15:25:24Z","timestamp":1772551524000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,3,3]]},"published-print":{"date-parts":[[2026,1]]}},"alternative-id":["10.1136\/lupus-2025-001821"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001821","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1]]}}}